Showing results (311-320 of 322) with videos related to
Sort By:
Pageof 33
Hypertension (Dallas, Tex. : 1979)|November 1, 1981
Antiadrenergic therapy: special aspects in hypertension in the elderlyF H Messerli, G R Dreslinski, F E Husserl, et al.Life Sciences|June 2, 1986
Dehydration attenuates the acute natriuretic response to rat atriopeptin III (rAPIII)F E Cole, K A Graci, N C Trippodo, et al.Hypertension (Dallas, Tex. : 1979)|July 1, 1997
Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study GroupE Reisin, M R Weir, B Falkner, et al.Circulation|June 1, 1984
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertensionH O Ventura, F H Messerli, E D Frohlich, et al.Clinical Nephrology|April 1, 1997
Accuracy of formula-derived creatinine clearance in paraplegic subjectsV Thakur, E Reisin, M Solomonow, et al.Cardiology|September 1, 1996
Analysis of adverse effects among patients with essential hypertension receiving an ACE inhibitor or a beta-blockerJ Rosenthal, H Bahrmann, K Benkert, et al.Kidney International|January 3, 2001
Effects of dehydroepiandrosterone and quinapril on nephropathy in obese Zucker ratsR J Richards, J R Porter, F Inserra, et al.Archives of Internal Medicine|January 1, 1981
Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activityF H Messerli, B Christie, J G DeCarvalho, et al.Federation Proceedings|August 1, 1986
Hemodynamic effects of atrial natriuretic hormoneB L Pegram, N C Trippodo, T Natsume, et al.Hypertension (Dallas, Tex. : 1979)|November 1, 1985
Rat platelets activate high molecular weight atrial natriuretic peptides in vitroN C Trippodo, A Januszewicz, B L Pegram, et al.Pageof 33